Mitochondrial Phosphoenolpyruvate Carboxykinase Regulates Osteogenic Differentiation by Modulating

Zheng Li1,2, Xuenan Liu1,2, Yuan Zhu1,2

  • 1Department of Prosthodontics, School and Hospital of Stomatology, Peking University, Beijing, People's Republic of China.

Insights

Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) positively regulates human mesenchymal stem cell (hMSC) osteogenesis by promoting autophagy via the AMPK/ULK1 pathway. This finding offers potential for bone tissue engineering and metabolic bone disease therapies.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Regenerative Medicine

Background:

  • Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) is crucial for energy metabolism, and its dysfunction causes metabolic disorders.
  • The role of PCK2 in human mesenchymal stem cell (hMSC) osteogenesis remains largely unexplored.
  • PCK2 is a key enzyme in gluconeogenesis and anabolism.

Purpose of the Study:

  • To investigate the novel function of PCK2 in regulating osteogenic differentiation of hMSCs.
  • To elucidate the mechanism by which PCK2 influences hMSC osteogenesis, focusing on its role in autophagy.
  • To explore the potential of PCK2 as a therapeutic target for bone regeneration and metabolic bone diseases.

Main Methods:

  • Utilized hMSCs to study PCK2's role in osteogenesis.
  • Manipulated PCK2 expression (deficiency and overexpression) to assess its impact on autophagy and osteogenic differentiation.
  • Investigated the signaling pathway involved, specifically the AMP-activated protein kinase (AMPK)/unc-51 like autophagy activating kinase 1 (ULK1) axis.
  • Assessed autophagy levels and osteogenic markers in hMSCs under different PCK2 conditions.

Main Results:

  • PCK2 deficiency impaired hMSC osteogenic differentiation and suppressed autophagy.
  • PCK2 overexpression promoted autophagy and enhanced osteogenic differentiation in hMSCs.
  • PCK2 regulates hMSC osteogenesis through an autophagy-dependent pathway mediated by AMPK/ULK1.
  • PCK2 integrates cellular metabolism, autophagy, and bone formation.

Conclusions:

  • PCK2 acts as a positive regulator of osteogenic differentiation in hMSCs.
  • PCK2's function in osteogenesis is mediated by its regulation of autophagy via the AMPK/ULK1 pathway.
  • PCK2 represents a novel target for enhancing stem cell-based bone tissue engineering and treating metabolic bone diseases.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.2K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
14.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
8.2K
Phosphorylation01:02

Phosphorylation

The addition or removal of phosphate groups from proteins is the most common chemical modification that regulates cellular processes. These modifications can affect the structure, activity, stability, and localization of proteins within cells as well as their interactions with other proteins.
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
53.5K
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
16.2K